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ABSTRACT
A Comparison of Heat Treatment-Induced Skeletal Muscle
Adaptations Relative to Exercise Training
Jamie Puanani Brun Kaluhiokalani
Department of Exercise Sciences, BYU
Master of Science
In vitro and animal studies indicate that the response to heat stress is associated with
beneficial adaptations that promote cell health and survival. Few studies to date have examined
this finding in human subjects, and it is unclear how the adaptation compares in magnitude to
exercise training. The purpose of this study was to investigate the skeletal muscle adaptations
(namely mitochondrial biogenesis and capillarization) of 6 weeks of deep-muscle heat treatment
relative to exercise training. We hypothesized that heat treatment (HT), applied through pulsed
shortwave diathermy (2 hr, 3 days/week) over a 6-week intervention period would lead to
increased mitochondrial content and capillarity within skeletal muscle, though to a lesser extent
than single-leg knee extension exercise training (EX; 40 min, 3 days/week). We randomized 28
sedentary but otherwise healthy, young adults (ages 18–36; n = 13 female, n = 15 male) to
receive either HT, EX, or sham heating sessions (CON; 2 hr, 3 days/week) over 6 weeks.
Diathermy increased muscle temperature by 3.2 ± 0.33 °C (P < 0.0001) within 20 minutes.
Muscle biopsies were taken from the vastus lateralis at baseline, after 3 weeks of intervention
and again after 6 weeks of intervention. Following 3 and 6 weeks of heat treatment, we did not
observe significant changes in mitochondrial biogenesis or capillarization. However, exercise
training was sufficient to elicit an increase in individual capillary-to-fiber ratio (P = 0.0003),
capillary density (P = 0.0428), and the Capillary to Fiber Perimeter Exchange Index (P =
0.0089). Significant increases in the expression of mitochondrial protein Complexes I (P =
0.0073) and IV (P = 0.0015), were observed in the exercise group, but not the heat or control
groups. These results indicate that 6 weeks of localized HT, when applied to young healthy
individuals, is insufficient to induce mitochondrial biogenesis or capillarization in skeletal
muscle. Additionally, our findings provide support for the extensive body of literature that
connect exercise training to beneficial skeletal muscle adaptations.
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Introduction
Skeletal muscle is a dynamic and adaptable tissue that contributes to mobility, exercise
capability, and the performance of activities of daily living (Frontera & Ochala, 2015). It
comprises approximately 40% of total body weight and can account for up to 90% of wholebody oxygen consumption and energy expenditure during exercise (Bodine et al., 2001). In
general, the homeostasis of muscle mass depends on the balance between protein synthesis and
degradation, with both processes being highly sensitive to factors such as hormonal balance,
nutritional status, physical activity/exercise, and injury or disease. From a metabolic perspective,
the roles of skeletal muscle include a contribution to basal energy metabolism, storing important
substrates such as amino acids and carbohydrates, helping to maintain homeostasis via heat
production, and consumption of the majority of oxygen and fuel used during physical activity
and exercise (Frontera & Ochala, 2015). Thus, the maintenance of healthy muscle throughout the
lifespan is vitally important to overall health and well-being (Agostini et al., 2018; Stanford &
Goodyear, 2014; Wolfe, 2006). Fortunately, skeletal muscle is a highly plastic tissue that adapts
relatively quickly in response to a variety of stresses.
It is recognized that endurance training elicits robust adaptations in skeletal muscle
(Hughes et al., 2018). Two of the primary underlying and most well-characterized of these
adaptations include increased microvascular density (Hoier et al., 2012) and mitochondrial
biogenesis (Booth et al., 2015; Camera et al., 2016; Holloszy, 1967). It is generally understood
that these adaptations arise from the amalgamation of myriad stresses imposed on the muscle by
exercise, including oxidative, metabolic, mechanical, and heat stresses (Hawley et al., 2018;
Lundby & Jacobs, 2015). While nearly all these stressors have been investigated for their role in
mediating improvements in skeletal muscle function, heat stress has received less attention.
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With the generation of heat being a major byproduct of exercise, it is likely that some of
the adaptations associated with exercise are attributable to exercise-induced heat production. The
primary purpose of these adaptations appears to be the protection against future disturbances that
might affect energy availability (Heinonen et al., 2011; Kim et al., 2019; Kuhlenhoelter et al.,
2016; Malanga et al., 2015). The cellular response to heat stress is associated with several
beneficial adaptations that promote cell health and survival (Giombini et al., 2009; Liu &
Brooks, 2012; Tamura et al., 2014). Specifically, repeated exposure to mild heat treatment (HT)
stimulates mitochondrial biogenesis (Hafen et al., 2018) and pro-angiogenic (Kuhlenhoelter et
al., 2016) adaptations in skeletal muscle. An increase in mitochondrial content can enhance the
ATP-generating capacity of skeletal muscle, thereby protecting it from future stress.
Additionally, increased microvasculature within skeletal muscle can improve the delivery of
oxygen and other nutrients when metabolic demand is increased. Together, these adaptations
demonstrate the improved capabilities of skeletal muscle following heat stress. Heat stress via
hot tub therapy has also been shown to improve insulin sensitivity (Geiger & Gupte, 2011;
Hooper, 1999) and lower levels of blood glucose in patients with type 2 diabetes (Archer et al.,
2018). Additionally, heat treatments at 41 to 41.5 °C, and the overexpression of HSP72 has been
found to prevent high-fat diet-induced insulin resistance in rodents (Chung et al., 2008). Previous
data generated in our laboratory provides evidence that repeated exposure to HT, applied via
pulsed shortwave diathermy, elicits one of the hallmark adaptations of exercise—improvements
in mitochondrial function (Hafen et al., 2018). However, it is currently unknown if the
magnitude of this adaptation is comparable to exercise training, or whether heat can mimic the
effects of exercise by altering the microvascular environment of the muscle. Therefore, my
primary objective was to examine the effect of 6 weeks of deep muscle heating on skeletal
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muscle adaptations including mitochondrial biogenesis and microvascular remodeling, relative to
the adaptations observed through exercise training. I hypothesized that 6 weeks of heat treatment
would increase mitochondrial content and capillarity within skeletal muscle relative to a sham
heat, but to a lesser extent than what we would observe through the exercise training
intervention.
Methods
Study Description
This was a randomized, single-blinded, placebo-controlled study to determine the
efficacy of passive heat treatment on outcomes related to lower extremity skeletal muscle health
(namely, mitochondrial content and angiogenesis) relative to exercise training. Healthy,
untrained volunteers (n = 28; 15 male, 13 female) enrolled in this study. While 30 participants
were initially randomized, two were unable to complete the study. Thus, data was collected and
analyzed from 28 participants. Characteristics of the participants can be seen in Table 1. Subjects
were considered healthy, as they reported no signs/symptoms of cardiovascular or metabolic
diseases. Additionally, they had not participated in any structured physical activity for the
preceding 3 months. The Brigham Young University Institutional Review Board approved this
study (IRB2020-023). Each volunteer was informed of the purpose of the study, experimental
procedures, and potential risks associated with the study before written consent was obtained.
Treatment Groups
Subjects were randomly assigned to the control, heat, or exercise group. One week after
the initial muscle biopsy, subjects began reporting to the laboratory 3 days a week for a 120-min
heating or control (HT and CON) session, or 40-min exercise session (EX) on the right leg. The
EX group underwent 6 weeks of knee extension (KE) exercise training using the exercise
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modality described in Testing for the knee extension exercise testing. Subjects performed a total
of 40 min of KE exercise 3 times per week. The intensity of exercise during each visit alternated
from light intensity (~20% KEmax) to 4-min bouts of high-intensity exercise (~80% KEmax).
Six minutes of light-intensity exercise (~40% KEmax) was performed at the start and end of
each exercise visit to allow the subject to adequately warm up and cool down. Passive heat
treatment (HT) was administered using shortwave diathermy (Megapulse II). Two diathermy
drums were placed directly on the vastus lateralis and turned on at 27.12 MHz and 800 bursts
per second. In order to heat muscles of the quadricep group evenly, the drums were alternated
from a more proximal to a more distal position every 20 min over each 2-hr HT bout. The
control (CON) subjects had nearly identical visits to those in the HT group. CON subjects were
asked to lie down, and two diathermy drums were placed over their quadriceps muscles. The
same settings that are used for HT were programmed for the CON group, however, the
diathermy session was not started.
Testing
On their first visit, all subjects had initial measurements (upper, middle, and lower thigh
circumference, a skinfold measurement, and thigh length) recorded, and provided a muscle
biopsy from the right vastus lateralis (detailed in Muscle Biopsy Protocol). Subjects in the EX
group also participated in a KE maximal (KEmax) exercise test. Subjects performed
the movement by kicking (extending) their leg from a flexed position to an extended position. As
the leg was attached to the pedals of an exercise bike with cuffs placed around the ankle area, the
kicking of their leg spun the pedals, which in turn, gently pulled the subject's leg back to the
starting, flexed position. Subjects repeated this extension exercise at a frequency of 80
revolutions per minute (rpm) for a few minutes to familiarize themselves with the movement.
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The maximum power each subject achieved during a graded exercise test was determined by first
having the subject perform a light warm up of knee extension exercise for 3–5 minutes, and then
incrementally increasing the resistance by 5–10 watt (W) each minute until the subject fatigued.
The final power output completed for 1 min was defined as KEmax. The test ended when the
subject was no longer able to maintain 75–80 rpm. The results of the KEmax test allowed us to
calibrate the training intervals of each EX subject. For example, if a subject achieved a KEmax
of 50 W, we alternated between 40 W (80% KEmax) and 10 W (20% KEmax) for their EX
intervention.
After 3 weeks of treatment/training (Visit 13), subjects underwent a midpoint testing day
with the same measures taken at Visit 1 (muscle biopsy and a new KEmax test if in the EX
group). The intervention visits then resumed for 3 more weeks. Posttraining testing was identical
to baseline testing. A schematic of the study design can be found in Figure 1.
Muscle Temperature Measurement
Regardless of treatment group, muscle temperature was monitored continuously
throughout the first intervention visit to ensure that intramuscular temperature did not exceed 42
°C and to provide evidence that our HT and EX treatments were increasing muscle temperature,
while CON was not. A small area on the skin over the vastus lateralis was cleaned with the
antiseptic chlorhexidine, and a local anesthesia (1% lidocaine with epinephrine) was then
injected. After the participant was able to report no sensation in the area, a flexible thermocouple
temperature probe (Physitemp Instruments, model IT-17:3, Clifton, NJ) was inserted
perpendicular to the muscle to a depth of approximately 3.5 cm using a small 18-gauge sterile
Cathlon I.V. catheter (Smiths Medical, Lancashire, UK). Once the temperature probe had been
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inserted into the muscle, the other end was plugged into an Iso-Thermex (Columbus Instruments,
model 256, Columbus, OH) machine. Temperature microprobes were held in place by tape.
Muscle Biopsy Protocol
Percutaneous needle biopsies were taken from the vastus lateralis muscles of the right leg
for assessment of mitochondrial content, capillary density, and protein expression. Biopsies were
taken from all subjects on the first visit, halfway through their assigned interventions, and upon
conclusion of the study. A small area on the skin over the vastus lateralis was shaved and then
cleaned with chlorhexidine. An injection of local anesthesia (1% lidocaine with epinephrine) was
then used to numb the area. After the participant was able to report no sensation in the area, a
small incision was made into the skin and fascia and the biopsy needle was inserted into the
muscle. Using manual suction, approximately 75–150 mg of tissue was withdrawn. Muscle
samples were then separated from any fatty tissue and divided into 25–50 mg portions. Portions
of tissue designated for protein analysis were frozen in liquid nitrogen, while portions designated
for sectioning and microscopic analysis of mitochondrial content and capillary density were
mounted on a cork with tragacanth gum and frozen in isopentane cooled in liquid nitrogen. All
frozen samples were stored at −80 °C. All biopsies were performed on the same leg and moved
proximally from the first incision approximately 1 cm for each subsequent biopsy.
Muscle Protein Measures
Protein Isolation
Frozen tissue samples were weighed and homogenized in T-PER Tissue Protein
Extraction Reagent (78510, Thermo Scientific, Rockford, IL) at a ratio of 9 µL per milligram of
tissue with the addition of a Halt Protease and Phosphatase Inhibitor Single-Use Cocktail 100X
(1861280, Thermo Scientific, Rockford, IL). Tissue disruption was performed on ice using a
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glass-on-glass Dounce homogenizer. The homogenate was centrifuged at 1000 g, 4 °C for 10
min. The supernatant was analyzed in duplicate for total protein concentrations with the BCA
Protein Assay Kit (product# 23225, Thermo Scientific Pierce, Rockford, IL). The supernatant
was stored at –80 °C.
Magnetic Bead Multiplex
Protein in muscle homogenates was measured with the Magpix (Luminex) multiplexing
platform using a 17-plex Human Angiogenesis/Growth Factor Magnetic Bead Panel (Cat#
HAGP1MAG-12K) in compliance with the manufacturer’s recommendations. All samples from
each subject were measured on the same plate to account for any variability that might be present
between plates. Analytes included Angiopoietin-2 (ANG-2), BMP-9, Epidermal Growth Factor
(EGF), Endoglin, Endothelin-1, Fibroblast Growth Factors 1 and 2 (FGF-1, -2), Follistatin,
Granulocyte Colony-Stimulating Factor (G-CSF), Heparin-binding EGF-like Growth Factor
(HB-EGF), Hepatocyte Growth Factor (HGF), Interleukin-8 (IL-8), Leptin, Placental Growth
Factor (PLGF), and Vascular Endothelial Growth Factors A, C, and D (VEGF-A, -C, -D).
Antibody-conjugated magnetic beads were incubated with 25 μL (final vol, 15 μL of tissue) of
tissue homogenate (roughly 130–150 μg protein/well) overnight at 4 °C on a plate shaker. Beadcomplexes were then washed and incubated in detection antibodies for 1 hr on a plate shaker at
room temperature (RT). This was followed by incubation in streptavidin phycoerythrin for 30
min on a plate shaker at room temperature. Bead-complexes were resuspended in Drive Fluid
and mixed on a plate shaker for 5 min, and then analyzed on the MAGPIX multiplex platform
(Luminex xMAP Technology, San Diego, CA, USA). For quantitative assays, standard curves
were generated from measures of protein standards. For qualitative assays, mean fluorescent
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intensity (MFI) values were recorded and used for data analysis. Data was analyzed using
Milliplex Analyst 5.1 software (Millipore Corporation, Billerica, MA, USA).
Capillary-Based Western Blot (Wes)
Mitochondrial protein Complexes I-V and PGC-1α protein expression were analyzed
using an automated capillary electrophoresis system Wes (ProteinSimple, San Jose, CA) with
capillary cartridges for 12–230 kDa protein separation module (#SM-W004; Protein Simple, San
Jose, CA). The protein concentrations were adjusted to 3.8 μg/mL for mitochondrial protein
Complexes I-V, and 1.8 μg/mL for PGC-1α using 0.1X sample buffer 2 (ProteinSimple, San
Jose, CA). The following primary antibodies were used: Total OXPHOS Human WB Antibody
Cocktail (ab110411, Abcam) and Anti-PGC-1 (AB3242, MilliporeSigma). All samples from
each subject were measured on the same plate to account for any variability that might be present
between plates. GAPDH (#2118, Cell Signaling Technology) was used as a protein loading
control. Signals were analyzed and visualized using Compass software (Compass for SW 6.0.0;
ProteinSimple, San Jose, CA).
Immunohistochemistry
Eight-micrometer cross-sections of muscle biopsy tissue samples were cut using a
cryostat at −25°C. Samples were mounted to Superfrost slides and air-dried for 10 min. Sections
were fixed in 2% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) for 7–8 min. Following
fixation, sections were washed in phosphate-buffered saline (PBS) solution 3 times for 2 or 3
min. Sections were then blocked in 0.2% Triton X-100, 2% bovine serum albumin (BSA), 5%
fetal bovine serum (FBS) solution for 30 or 60 min at RT in a humidified container. Sections
were incubated in the appropriate primary antibody in a humidified chamber overnight at 4 °C.
Following several washes, sections were then incubated in the appropriate secondary antibody
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for 30 min at 37 °C. Sections were washed multiple times and rinsed in ultra-pure water. Stained
slides were then dried and mounted using Fluoroshield histology mounting medium (Sigma–
Aldrich, St. Louis, MO). The following primary antibodies were used: CD31, mouse monoclonal
(1:100; Agilent, Santa Clara, CA) and Dystrophin, rabbit polyclonal (1:200; Abcam: AB15277,
Cambridge, MA). Secondary antibodies included: Alexa Fluor 488 goat anti-mouse (1:100;
Abcam, Cambridge, MA) and Cy3 goat anti-rabbit (1:100; Jackson ImmunoResearch
Laboratories, West Grove, PA).
Quantification of Immunofluorescent Images
All image quantification was accomplished using Olympus CellSens software by an
investigator that was blind to group and time point. For the capillary analysis, fiber crosssectional areas and perimeters were determined using Myosoft on Fiji ImageJ. Capillary contacts
and capillary sharing factors were quantified using Olympus CellSens software. Capillary-tofiber ratio of CD31 stained images was determined by quantifying the number of capillary
contacts and the sharing factor for each capillary. The fractional contribution of capillary
contacts was summed to calculate the effective number of capillaries serving each muscle fiber.
Capillary-to-fiber perimeter exchange index (CFPE Index) was calculated as the quotient of the
capillary-to-fiber ratio and fiber perimeter. Capillary density was calculated as the quotient of the
capillary-to-fiber ratio and fiber cross-sectional area.
Statistical Analysis
A mixed model analysis of variance (ANOVA) was used to examine the main effects of
time (pre vs. mid vs. post) and intervention (control vs. heat vs. exercise) in conjunction with the
interaction of group × time to test changes within and between groups for capillarization indices
and biomarkers, mitochondrial respiratory complex proteins, and PCG-1α protein expression. A
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Tukey-Kramer HSD test was performed post hoc when the fixed-effect test revealed a significant
p-value for main effects or the group × time interaction. Analyses were completed using JMP Pro
statistical software, version 15.0. Alpha was set at P < 0.05. Data are expressed as means ± SD.
Results
Intramuscular Temperature During Intervention
Temperature data were collected on 7–8 subjects in each group to ensure that sufficient
data was collected to determine whether our interventions were affecting intramuscular
temperatures as hypothesized. Vastus lateralis temperature in the HT group increased 3.2 ±
0.33 °C (P < 0.0001) within 20 min of application of shortwave diathermy and it remained
elevated from baseline for the remaining 1.5-hr heating session. Periodic decreases in
temperature can be observed through the heat session, perhaps due to the alternating placement
of the two diathermy drums. Despite the movement of the drums, intramuscular temperatures
remained significantly elevated for the entirety of the session relative to baseline or CON
conditions. In the EX group, intramuscular temperatures increased by 1.8 ± 0.42 °C (P < 0.0001)
by 10 min and remained elevated for the following 30 min of the training bout. In the CON
group, intramuscular temperatures did not change significantly over the course of the session
(Figure 2).
Muscle Capillarization
The impact of EX and HT on muscle capillarization can be found in Figure 3. No
significant main effect of group (P = 0.2014) was detected for the individual capillary-to-fiber
ratio (C/Fi) following 6 weeks of intervention. A significant main effect of time (P < .0001) was
observed, and post hoc analysis revealed this difference to be in the EX group from pre to post (P
= 0.0003). Post hoc analysis on our group × time interaction (P = .0408) revealed a significant
10

difference between EX and CON subjects following 6 weeks of intervention. There were no
significant changes in C/Fi at 3 or 6 weeks in either the HT or CON groups (Figure 3D).
Additionally, when data were analyzed per volume (capillary density (CD)), no significant
main effect of group (P = 0.2445) was detected following 6 weeks of intervention. A significant
main effect of time (P = 0.0028) was observed, and post hoc analysis revealed this difference to
be in the EX group from pre to post (P = 0.0428; Figure 3E). There were no significant changes
in CD at 3 or 6 weeks in either the HT or CON groups (Figure 3E).
Similarly, analysis of the Capillary to Fiber Perimeter Exchange Index (CFPE Index)
revealed that no significant main effect of group (P = 0.4182) was detected following 6 weeks of
intervention. A significant main effect of time (P = 0.0006) was observed, and post hoc analysis
revealed this difference to be in in the EX group from pre to post (P = 0.0089; Figure 3F). There
were no significant changes in the CFPE Index at 3 or 6 weeks in either the HT or CON groups
(Figure 3F).
Molecular Indicators of Angiogenesis
To more globally assess angiogenic signaling in the vastus lateralis, we performed a
quantitative immunomagnetic bead screen of 17 molecular markers that are associated with
angiogenesis. The results of this screen can be found in Table 2. In total, 14 of the 17 analytes
were detected within skeletal muscle. Overall, HT had little effect on expression of these
markers, but EX elicited significant changes in many of the markers. As indicated in Table 2,
Angiopoietin-2 (ANG-2), Fibroblast Growth Factor (FGF-1), Hepatocyte Growth Factor (HGF),
Placental Growth Factor (PLGF), and Vascular Endothelial Growth Factor A (VEGF-A)
increased significantly from baseline following 6 weeks of exercise training.
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Mitochondrial Biogenesis
To determine whether the heat intervention resulted in de novo synthesis of
mitochondria, mitochondrial biogenesis was measured in two ways. We measured the
concentrations of 3 mitochondrial respiratory chain subunits (Complex I, II, and IV), as well as
protein expression of PGC-1α, an upstream regulator of mitochondrial biogenesis. Following 6
weeks of intervention, no significant main effect of group (P = 0.1305) was observed in the
expression of Complex I. A significant main effect of time (P = 0.0307) was observed, and post
hoc analyses revealed these differences to be in the EX group following 3 weeks (P = 0.0129)
and 6 weeks (P = 0.0073) of intervention (Figure 4A). No significant main effect of group (P =
0.4773) or main effect of time (P = 0.4608) was detected in Complex II protein expression
(Figure 4B). Additionally, no significant main effect of group (P = 0.0982) was observed in the
expression of Complex IV following 6 weeks of intervention. A significant main effect of time
(P = 0.0005) was observed, and post hoc analyses revealed these differences to be in the EX
group following 3 weeks (P = 0.0133) and 6 weeks (P = 0.0015) of exercise training (Figure 4C).
There were no changes in the protein expression of mitochondrial Complexes I, II, and
IV in HT or CON groups. Finally, no significant main effect of group (P = 0.7614) or main effect
of time (P = 0.6678) was observed for PGC-1α protein expression (Figure 4E).
Discussion
The purpose of this study was to examine the skeletal muscle adaptations induced by HT,
namely microvascular remodeling and mitochondrial biogenesis, relative to exercise training.
Previous work from our laboratory has shown that the application of heat treatment (2 hr/day)
over the course of 6 days was sufficient to induce mitochondrial adaptation, but it was unclear
how this adaptation compared in magnitude to exercise training (Hafen et al., 2018).
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Furthermore, a recent study by Hesketh et al. (2019) has indicated that heating may also induce
an angiogenic response reminiscent to that which occurs with exercise training, though studies
are still limited at this point. Contrary to our hypotheses, we found that 6 weeks of HT
administered to the knee extensor muscle group using shortwave diathermy, did not elicit
significant increases in either skeletal muscle capillarization or mitochondrial content. We also
report that 6 weeks of high-intensity interval single-leg knee extension exercise was sufficient to
induce both mitochondrial biogenesis and microvascular remodeling in the vastus lateralis.
Kuhlenhoelter et al. (2016) first reported that after an acute bout of lower body heating or
unilateral thigh heating, the mRNA expression of angiogenic regulators in healthy young adults
increased significantly. Subsequently, Kim et al. (2020) reported that the expression of proangiogenic factor VEGF was enhanced after a single session, as well as after 5 days of repeated
exposure to HT. These studies suggested that a long-term application of HT may induce
angiogenesis in skeletal muscle. In accordance, Hesketh et al. (2019) recently reported
improvements in skeletal muscle capillarization similar to those induced by moderate intensity
continuous training (MICT) following 6 weeks of whole body passive heat treatment (40–50 min
at 40 °C in a heat chamber, 3 days/week) in healthy, untrained adults. In contrast to their
findings, we did not observe increases in any index of capillarity or the expression of proangiogenic factors after our 6-week intervention of localized deep-muscle heat treatment. This
can potentially be explained by the differing time courses, subject characteristics, and heating
modalities used by the prior studies. For example, the higher level of physical activity that was
accepted by Hesketh et al. (2019) among their participants may have contributed to the
angiogenic benefits that they observed following HT intervention. This is evidenced through the
increased maximal rate of oxygen consumption (V̇O₂ max) observed in the HT and MICT groups
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alike. Whereas their exclusion criteria included exercising more than 150 min/week, we did not
allow any structured physical activity. Additionally, most of the recent heat studies (Hesketh et
al., 2019; Kim et al., 2020) have used heating modalities that heated a greater portion of muscle
mass (i.e., whole lower body), and/or likely elicited some systemic effects in addition to those
observed within the skeletal muscle specifically. For example, Hesketh et al. (2019), who
reported increased capillary density following a similar 6 weeks of intervention, utilized a
protocol in which their participants sat in a heat chamber, a systemic form of HT. On the other
hand, Kim et al. (2020), whose form of HT was more localized (52 °C water, perfused through
trousers for 90 min, 5 days/week for 8 weeks), elicited no significant improvements in VEGF,
ANG1, or capillary contacts. It is therefore reasonable to question whether or not our localized
diathermy heating did not promote greater systemic effects that may contribute to skeletal
muscle adaptations. For instance, existing literature associates sauna bathing, a form of systemic
passive heating, with better cardiovascular and circulatory function in humans (Hesketh et al.,
2019; Laukkanen et al., 2015). The exact mechanisms of these circulatory benefits are not well
understood at present, but it is plausible that increased capillarity is a contributor. Though the
literature regarding whole-body HT and its potential effects within human skeletal muscle is
limited, several murine studies have demonstrated a strong connection between HT and elevated
pro-angiogenic factors in the heart (Gong et al., 2006; Ihori et al., 2016) and skeletal muscle
(Akasaki et al., 2006; Miyauchi et al., 2012) of mice and rats. While these studies provide
promising evidence for the benefits of heat treatment, the underlying molecular mechanisms of
these adaptations remain unclear. Perhaps skeletal muscle adaptations are more likely to be
elicited through systemic, rather than localized HT, and this raises an interesting question for
future research.
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Consistent with prior studies, 6 weeks of EX training led to improvements in skeletal
muscle capillarization. Expression of CD31, as well as the expression of pro-angiogenic factors
such as VEGF-A, HGF, and ANG-2 all increased significantly with EX training. This finding
provides further support to previous studies that have reported beneficial microvascular skeletal
muscle adaptations following at least 6 weeks of exercise training (Hesketh et al., 2019; Hoier &
Hellsten, 2014; Li et al., 2020).
Contrary to our hypothesis, no changes were observed that would be consistent with
mitochondrial biogenesis after 6 weeks of HT intervention. Our hypothesis was primarily based
on the results of Hafen et al. (2018), who used the same modality (2 hr of pulsed shortwave
diathermy daily for 6 consecutive days) and reported increases in both PGC-1α and
mitochondrial electron transport chain (ETC) protein Complexes I and V. However, increases in
mitochondrial function in response to HT has not necessarily been a universal finding in the
literature. Both Kim et al. (2020) and Hesketh et al. (2019) reported that local HT had no effect
on respiratory chain protein content. Like us, both of these studies implemented extended heating
protocols (6–8 weeks). Together, the findings of our study and those recently conducted by Kim
et al. (2020) and Hesketh et al. (2019), indicate that 6 weeks of repeated bouts of heat therapy
may be insufficient to increase long-term mitochondrial content in healthy, untrained adults. It is
worth noting that Hafen et al. (2018) did not see an increase in maximal enzymatic activity of
citrate synthase (CS), a common surrogate marker of mitochondrial content. However, Hafen et
al. (2018) reported significant augmentation of maximal coupled and uncoupled respiratory
capacity using high-resolution respirometry. This finding may indicate that HT, rather than
signaling for increased mitochondrial content, could possibly lead to improved efficiency of
existing mitochondria. At present, there is still a lack of research investigating the effects of HT
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on skeletal muscle mitochondrial biogenesis. Further research is necessary to better understand
the ways in which mitochondria respond to HT, and the specific mechanisms by which any
benefits are derived. Additionally, as we measured only two markers of mitochondrial biogenesis
(respiratory protein complexes and PGC-1α protein expression), it is possible that a more
comprehensive investigation would have captured adaptations that we were unable to observe
through the present study.
In contrast to the findings of HT, 6 weeks of our EX training intervention was sufficient
to induce increased mitochondrial content. Although we were only able to attain reliable data for
3 of the 5 mitochondrial respiratory protein complexes, significant increases were observed in
Complexes I and IV, at both 3 and 6 weeks of EX. These results add to the extensive body of
literature that supports exercise training as a means of improving skeletal muscle mitochondrial
biogenesis (Montero et al., 2015; Murias et al., 2011; Vincent et al., 2015). A recent study by
MacInnis et al. (2017) reported that following 6 sessions of single-leg cycling, Complex IV
protein content increased by 24% posttraining. This is in line with our finding that 6 weeks of
single leg knee extensions led to a significant increase in Complex IV protein expression
posttraining (P = 0.0015). Further research may be helpful for determining optimal exercise
training protocols to elicit maximal improvements in mitochondrial biogenesis, but that is
beyond the scope of this study.
Additionally, we did not observe an increase in PGC-1α expression in any of our
intervention groups. However, as PGC-1α is not a terminal marker of mitochondrial biogenesis,
it is possible that this upstream regulator increased early in our intervention period or acutely
following each exercise bout. Support for this conjecture is provided by Gibala et al. (2009) and
Baar et al. (2002), who reported elevated PGC-1α, 3 and 6 hours postexercise, respectively. As
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our muscle biopsies were performed approximately 48 hours postintervention, it is possible that
we were unable to capture the acute upregulation of PGC-1α.
We chose to apply local HT for 120 minutes, as this dose has previously been shown,
when applied over a shorter time course (6–14 consecutive days), to increase mitochondrial
biogenesis and PGC-1α expression, attenuate the reduction in angiogenic signaling associated
with limb disuse (unpublished data), and increase the expression of heat shock proteins (Hafen et
al., 2018; Ogura et al., 2007; Touchberry et al., 2008). One unintended consequence of this
protocol was that some participants reported the inability to maintain their habitual levels of
physical activity throughout the study. The additional 2 hr of sitting, 3 days/week, could have
decreased the amount of time that participants may have spent on physical activities such as
walking to campus, grocery shopping, or light recreational games with friends. Recently, several
studies have used progressive step reduction interventions as a model of muscle disuse/atrophy
(Bowden Davies et al., 2018; Krogh-Madsen et al., 2010; Olsen et al., 2008). These studies
reduced ambulatory activity for 14 days (participants asked to reduce their activity to ~1500
steps/day) and all reported decreased cardiorespiratory fitness, dyslipidemia, and importantly,
reduced insulin sensitivity within skeletal muscle (Bowden Davies et al., 2018; Krogh-Madsen et
al., 2010). Krogh-Madsen et al. (2010) also reported a 0.5 kg decrease in leg lean mass in their
healthy young subjects. Taken together, the results of these step reduction studies demonstrate
the potency of decreased ambulation as a means of skeletal muscle deconditioning. While our
protocol likely did not lead to such a drastic step reduction, it was perhaps ample enough to
overshadow any potential benefits of the heat treatment. Perhaps the additional sedentary time
was not enough to elicit maladaptation below baseline (hence the lack of significant decreases in
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HT and CON groups), but it may have been sufficient to prevent any potential mitochondrial or
pro-angiogenic remodeling following 6 weeks of HT.
Conclusion
In conclusion, 6 weeks of localized heat treatment, applied to the knee extensor muscles
through pulsed shortwave diathermy, appears to be insufficient to induce skeletal microvascular
remodeling and increased mitochondrial biogenesis in healthy, untrained adults. Further research
is necessary to determine if heat treatment may illicit beneficial skeletal muscle adaptations in
other populations (i.e., elderly, injured, or bedridden adults), serving as more of a protective
mechanism against muscle maladaptation. Additionally, our findings among the EX group align
with existing literature, in that 6 weeks (40 min, 3 days/week) of exercise training is sufficient to
induce skeletal muscle mitochondrial biogenesis, as well as increased capillarization.
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Table 1. Subject Characteristics

Age, years
Height, cm
Mass, kg
Thigh skinfold thickness, mm

Control
Male (n = 5) Female (n = 4)
21.4 ± 1.7
19.5 ± 1.9
178.2 ± 9.8
166.3 ± 7.3
62.6 ± 4.7
56.5 ± 8.5
5.8 ± 1.1
13.0 ± 3.5

Heat
Male (n = 6) Female (n = 4)
23.2 ± 6.6
19.5 ± 1.4
170.8 ± 5.2
168.5 ± 4.1
68.4 ± 12.2
51.4 ± 3.9
9.7 ± 3.7
10.6 ± 3.0
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Exercise
Male (n = 4) Female (n = 7)
25.3 ± 5.6
21.3 ± 5.8
177.5 ± 7.0
166.3 ± 5.8
75.4 ± 12.9
63.2 ± 16.6
7.5 ± 3.5
15.0 ± 4.3

Table 2. Angiogenic Markers
Analyte

Group
CON
Angiopoietin-2 (ANG-2)
HT
EX
CON
Epidermal Growth Factor (EGF)
HT
EX
CON
Endoglin
HT
EX
CON
HT
Endothelin-1
EX
CON
Fibroblast Growth Factor (FGF-1) HT
EX
CON
Fibroblast Growth Factor (FGF-2) HT
EX
CON
HT
Follistatin
EX
CON
Granulocyte Colony-Stimulating
HT
Factor (G-CSF)
EX
CON
Heparin-binding EGF-like
HT
Growth Factor (HB-EGF)
EX

Baseline
(pg ml-1)
647.90 ± 338.83
523.33 ± 402.77
444.93 ± 280.73
1.95 ± 0.67
1.73 ± 0.56
2.49 ± 2.16
6188.63 ± 1756.9
4041.90 ± 3295.64
3797.80 ± 2988.64
4.39 ± 0.97
3.70 ± 1.11
3.87 ± 1.25
48.13 ± 23.27
49.32 ± 16.06
48.87 ± 10.66
5003.63 ± 1468.7
2099.44 ± 771.09
2502.13 ± 1987.6
144.87 ± 43.35
152.79 ± 55.36
140.18 ± 37.47
24.63 ± 16.09
33.78 ± 15.60
32.10 ± 12.69
42.27 ± 22.22
15.84 ± 19.29
17.15 ± 10.97

Mid (wk 3)
(pg ml-1)
1429.52 ± 691.53
790.85 ± 565.91
1284.06 ± 985.96
2.06 ± 0.99
1.73 ± 0.47
1.81 ± 0.96
8422.25 ± 2853.9
3184.40 ± 1993.92
4681.60 ± 3269.06
4.43 ± 1.14
4.04 ± 1.80
3.95 ± 1.20
57.22 ± 11.36
53.17 ± 15.45
59.35 ± 18.58
4747.50 ± 2020.3
1985.78 ± 918.2
3447.01 ± 2906.9
138.34 ± 29.10
203.94 ± 142.58
176.79 ± 95.00
18.62 ± 8.04
35.18 ± 14.2
28.05 ± 10.1
56.54 ± 16.65
9.94 ± 6.93
27.79 ± 21.21
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Post (wk 6)
(pg ml-1)
1612.19 ± 1572.9
786.95 ± 748.21
1020.97 ± 690.32
2.09 ± 0.90
1.96 ± 0.89
1.90 ± 0.94
7819.90 ± 2888.66
3481.56 ± 2667.3
5319.44 ± 5468.8
4.43 ± 0.73
3.40 ± 1.06
4.29 ± 1.25
55.04 ± 16.04
57.72 ± 15.26
56.72 ± 13.95
4986.88 ± 2721.7
2811.00 ± 1669.56
2774.47 ± 2060.4
153.60 ± 55.71
197.11 ± 151.44
180.10 ± 120.66
23.96 ± 8.14
33.17 ± 15.58
33.38 ± 17.58
38.17 ± 19.29
15.18 ± 11.67
24.27 ± 23.35

Group

Time

Group ×
Time

0.80

< 0.0001*

0.19

0.84

0.78

0.73

0.96

0.09

0.43

0.94

0.75

0.46

0.091

0.0040*

0.88

0.87

0.51

0.17

0.84

0.30

0.83

0.64

0.58

0.76

0.30

0.16

0.17

Analyte

Group

Baseline
(pg ml-1)

Hepatocyte Growth Factor (HGF)

CON
HT
EX

949.82 ± 293.48
481.24 ± 374.87
596.72 ± 512.54

2687.25 ± 2901.9
598.13 ± 376.49
972.37 ± 808.05

Placental Growth Factor (PLGF)

CON
HT
EX

11.14 ± 2.25
11.50 ± 5.85
9.82 ± 4.00

Vascular Endothelial Growth
Factor A (VEGF-A)

CON
HT
EX
CON
HT
EX
CON
HT
EX

Vascular Endothelial Growth
Factor C (VEGF-C)
Vascular Endothelial Growth
Factor D (VEGF-D)

Mid (wk 3)
(pg ml-1)

Post (wk 6)
(pg ml-1)

Group

Time

Group ×
Time

2072.65 ± 1094.4
854.43 ± 654.7
1022.05 ± 1137.7

0.63

< 0.0001*

0.59

18.94 ± 7.19
15.26 ± 6.32
19.76 ± 9.40

18.35 ± 9.68
17.55 ± 14.50
16.61 ± 10.05

0.64

< 0.0001*

0.68

1261.28 ± 294.54
989.99 ± 939.81
950.78 ± 517.0

1671.03 ± 466.38
737.66 ± 546.26
1929.81 ± 1390.8

1432.95 ± 804.22
788.46 ± 493.27
1257.06 ± 933.97

0.26

0.032*

0.036*

24.16 ± 13.39
18.53 ± 6.70
22.31 ± 10.64
23.24 ± 7.55
12.04 ± 5.85
12.94 ± 8.82

29.17 ± 14.08
20.68 ± 10.59
22.91 ± 10.19
20.80 ± 6.69
13.64 ± 15.07
13.44 ± 6.81

23.16 ± 9.21
22.19 ± 9.70
21.25 ± 7.32
21.87 ± 6.07
12.89 ± 9.16
12.26 ± 6.95

0.44

0.51

0.92

0.42

0.99

0.80

Week 3 and week 6 indicate changes from baseline values after 3 weeks and 6 weeks of intervention.
Values are means ± SD.
*P < 0.05, significant difference from baseline, n = 8 CON, 10 HT, 10 EX.
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Figure 1. Study Design
Each participant was randomly assigned to receive pulsed shortwave diathermy treatments (HT),
participate in 40-min exercise sessions (EX), or receive a sham heat treatment (CON). Following
baseline vastus lateralis muscle biopsies and group randomization, participants engaged in 3
weeks of intervention. Midpoint biopsies were taken after 3 weeks, and were followed by 3
additional weeks of treatment before post biopsies were taken.
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Figure 2. Muscle Temperature
Intramuscular temperature was recorded during the first treatment in all groups at a depth of ~3
to 3.5 cm. Data are expressed as means ± SD; n = 7 CON, 8 HT, 8 EX.
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Figure 3. Capillarization Measures
(A–C) Representative skeletal muscle cross-sections displaying immunoreactivity for dystrophin
(red) and CD31 (green), from left to right, images were taken from pre-, mid-, and
postintervention biopsies of a subject in the exercise group. (D) Changes from baseline in the
ratio of the number of capillaries to each muscle fiber (C/Fi ). (E) Changes from baseline in
capillary density. (F) Changes from baseline in the capillary-to-fiber perimeter exchange index
(CFPE Index). Data were analyzed with a 2-way repeated measures ANOVA.
*Main effect of time (P < 0.05); #P < 0.05 from CON; n = 8 CON, 9 HT, 9 EX.
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Figure 4. Mitochondrial Biogenesis

(A–C) Western blot results for changes in protein expression of 3 mitochondrial respiratory proteins,
[NADH] oxidase (I), succinate dehydrogenase (II), and cytochrome c oxidase (IV). Summary of changes
in mitochondrial respiratory proteins from baseline after 3 and 6 weeks of intervention. (D, F)
Representative protein immunoblots for the mitochondrial respiratory proteins, PGC-1α, and GAPDH.
(E) Summary of changes in PGC-1α protein expression from baseline after 3 and 6 weeks of intervention.
Data are expressed as means ± SD; *P < 0.05, significant difference from baseline; n = 8 CON, 8 HT, 9
EX.
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